Stock listing

Frankfurt:PMRA Pharma Mar SA Aktie

German listing (Frankfurt) of Pharma Mar SA · home listing BME:PHM

Follow Pharma Mar SA into a list and get an email when it puts out news.

Share price · FWB:PMRA

€58.35 EUR -3.85 (-6.2%)

Close on Nov 20, 2026

Past year -15.7% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€58.35 – €58.35 EURNov 20, 2026
Market cap
€1.01B EURAt the close on Nov 20, 2026 · price × 17.26M shares outstanding
52-week range
€58.35 – €106.02 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€2,871 EURMedian day 0 shares · 51 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Pharma Mar SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:PHM · Home€57.80 EUR-4.25 (-6.8%)99,554€58.60€58.60€57.15€62.05Close on Nov 20, 2026
OTC:PHMMF$66.95 USD-5.592 (-7.7%)100$66.95$66.95$66.95$72.54Close on Nov 18, 2026
Frankfurt:PMRA€58.35 EUR-3.85 (-6.2%)—€58.35€58.35€58.35€62.20Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:PMRA · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€65.07-2.797-4.1%€65.07€65.07€65.070
€67.87+4.004+6.3%€67.87€67.87€67.87808
€63.86-0.434-0.7%€63.86€63.86€63.86808
€64.30-2.84-4.2%€64.39€64.41€64.300
€67.14-2.268-3.3%€67.14€67.14€67.140
€69.41+0.526+0.8%€69.41€69.41€69.41238
€68.88+0.438+0.6%€68.88€68.88€68.88294
€68.44+0.96+1.4%€68.44€68.44€68.44254
€67.48-1.662-2.4%€67.48€67.48€67.480
€69.14-1.309-1.9%€69.14€69.14€69.140
€70.45+1.202+1.7%€70.45€70.45€70.450
€69.25+0.502+0.7%€69.25€69.25€69.250
€68.75+1.389+2.1%€68.75€68.75€68.750
€67.36+0.25+0.4%€67.36€67.36€67.360
€67.11-1.214-1.8%€67.11€67.11€67.110
€68.32+1.669+2.5%€68.32€68.32€68.320
€66.65+0.158+0.2%€66.65€66.65€66.650
€66.50-1.591-2.3%€66.50€66.50€66.500
€68.09-1.684-2.4%€68.09€68.09€68.090
€69.77+0.491+0.7%€69.77€69.77€69.770
€69.28+0.158+0.2%€69.28€69.28€69.280
€69.12-0.72-1.0%€69.12€69.12€69.120
€69.84+0.714+1.0%€69.84€69.84€69.840
€69.13-1.946-2.7%€69.13€69.13€69.130
€71.07+0.65+0.9%€71.07€71.07€71.070
€70.42-2.352-3.2%€70.42€70.42€70.420
€72.78+0.239+0.3%€72.78€72.78€72.780
€72.54-0.87-1.2%€72.54€72.54€72.540
€73.41-0.284-0.4%€73.41€73.41€73.410
€73.69-0.245-0.3%€73.69€73.69€73.690
€73.94+1.172+1.6%€73.94€73.94€73.940
€72.76-1.643-2.2%€72.76€72.76€72.760
€74.41+0.764+1.0%€74.41€74.41€74.410
€73.64+0.0240.0%€73.64€73.64€73.640
€73.62-1.259-1.7%€73.62€73.62€73.620
€74.88-2.184-2.8%€74.88€74.88€74.880
€77.06+1.241+1.6%€77.06€77.06€77.060
€75.82-0.431-0.6%€75.82€75.82€75.820
€76.25-0.174-0.2%€76.25€76.25€76.250
€76.43-0.553-0.7%€76.43€76.43€76.430
€76.98-1.357-1.7%€76.99€77.42€76.1040
€78.34-0.468-0.6%€78.34€78.34€78.340
€78.80-2.664-3.3%€78.80€78.80€78.800
€81.47-1.352-1.6%€81.47€81.47€81.470
€82.82-0.384-0.5%€82.82€82.82€82.820
€83.20+1.028+1.3%€83.20€83.20€83.200
€82.18+0.401+0.5%€82.18€82.18€82.180
€81.78+0.823+1.0%€81.78€81.78€81.780
€80.95-1.496-1.8%€80.95€80.95€80.950
€82.45-0.626-0.8%€82.45€82.45€82.450
€83.07-0.732-0.9%€83.07€83.07€83.070
€83.81+0.58+0.7%€83.81€83.81€83.810
€83.23+1.339+1.6%€83.23€83.23€83.230
€81.89-2.384-2.8%€81.89€81.89€81.890
€84.27+1.299+1.6%€84.27€84.27€84.270
€82.97+1.86+2.3%€82.97€82.97€82.970
€81.11+0.26+0.3%€81.11€81.11€81.110

Splits

1 split · FWB:PMRA · every price before a split is adjusted for it

DayRatioWhat
1-for-12Consolidation
Ticker
Frankfurt:PMRA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Pharma Mar SA news

Pharma Mar SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 7 in all · newest Mar 13, 2026 · oldest 2017
Calls
2 calls with a replay · 2 with a transcript · latest Oct 27, 2023
Decks
33 decks · latest September 2026

Where Pharma Mar SA is listed

ListingExchangeCountryCurrency
BME:PHM · Home listingMadridSpainEUR
gettex:PMRAgettexGermanyEUR
VIE:PHMViennaAustriaEUR
OTC:PHMMFOTCUnited StatesUSD
LS Exchange:A2P9YTLS ExchangeGermanyEUR
Tradegate:PMRATradegateGermanyEUR
LSIN:0RC6LSINUnited KingdomEUR
Lang & Schwarz:A2P9YTLang & SchwarzGermanyEUR
Aquis:PHMEAquisUnited KingdomEUR
Dusseldorf:PMRADusseldorfGermanyEUR
Stuttgart:PMRAStuttgartGermanyEUR
Aquis:PHMEAquisUnited KingdomEUR
Turquoise:PHMETurquoiseUnited KingdomEUR
Frankfurt:PMRA · This pageFrankfurtGermanyEUR
Hamburg:PMRAHamburgGermanyEUR
Munich:PMRAMunichGermanyEUR

Valuation

P/E 14.6× against a median of 102×: the lowest of 2 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
€891.6M EUR
P/E
14.6×
EV/sales
3.8×
EV/EBITDA
16.6×
Price/book
4.2×
Gross margin
90.7%
Operating margin
19.1%
Net margin
28.8%
Debt to equity
0.3×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Pharma Mar SA · BME:PHMUS$1.10BUS$978.5M14.6×3.8×16.6×4.2×28.8%0.3×n/a
CStone Pharmaceuticals · HKEX:2616US$1.16BUS$974.9Mn/a24.1×n/a6.0×−162.1%0.3×n/a
Structure Therapeutics, Inc. · NASDAQ:GPCRUS$1.15B−US$82.92Mn/an/an/a0.9×n/a0.0×1.38
COMPASS Pathways Plc · NASDAQ:CMPSUS$1.14BUS$747.8Mn/an/an/a8.0×n/a0.4×1.65
Ascentage Pharma Group International · HKEX:6855US$1.11BUS$1.14Bn/a13.7×n/a13.4×−216.5%3.8×n/a
Shenzhen Chipscreen Biosciences Co. Ltd. Class A · SSE:688321US$1.10BUS$1.10B102×6.8×n/a2.9×6.6%0.5×n/a
Alpha Tau Medical Ltd · NASDAQ:DRTSUS$1.09BUS$1.00Bn/an/an/a55.3×n/a0.8×1.89
Kardigan, Inc. · NASDAQ:KARDUS$1.08BUS$621.1Mn/an/an/a1.9×n/a0.0×n/a
PYC Therapeutics Limited · ASX:PYCUS$1.07BUS$775.8Mn/an/an/a2.3×n/a0.0×n/a
Jade Biosciences, Inc. · NASDAQ:JBIOUS$1.06BUS$583.6Mn/an/an/a2.3×n/a0.0×1.14
MedinCell SA · EURONEXT:MEDCLUS$1.05BUS$1.02Bn/a38.4×n/a313×−128.9%18.7×n/a
Median of the othersUS$1.09BUS$875.4M102×18.9×4.4×−145.5%0.3×1.52

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
98.94 EUR · Analysts' mean
EPS, year to Dec 2026
2.08 · 6 analysts
Revenue, year to Dec 2026
220.3M · 5 analysts

Team and board

OfficerRole
Miriam Collados GordoCorporate Communications Manager
Natalia AmoCapital Markets & Investor Relations
Luis MoraManaging Director

Events

Next results
Feb 25, 2027 (expected)

Results days

QuarterResultsShare move
Q3 2026Oct 29, 2026 · After close−2.5%
Q2 2026Jul 29, 2026 · After close−1.1%
Q1 2026Apr 27, 2026 · After close+1.9%
Q4 2025Mar 5, 2026 · After close+0.3%
Q3 2025Oct 30, 2025 · After close−1.4%
Q2 2025Jul 30, 2025 · After close−0.6%
Q1 2025Apr 24, 2025 · After close−10.3%
Q4 2024Feb 26, 2025 · After close−0.3%
Q3 2024Oct 29, 2024 · After close−0.1%
Q2 2024Jul 30, 2024 · After close−0.7%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 23, 2024 · After close+3.0%
Q4 2023Feb 28, 2024 · After close−3.9%
Q3 2023Oct 26, 2023 · After close+3.2%
Q2 2023Jul 27, 2023 · After close−0.8%
Q1 2023Apr 27, 2023 · After close+2.3%
Q4 2022Feb 28, 2023 · After close−2.4%
Q3 2022Oct 26, 2022 · After close−0.9%
Q2 2022Jul 28, 2022 · After close−5.5%
Q1 2022Apr 28, 2022 · Before open+0.2%
Q4 2021Feb 28, 2022 · Before open+6.2%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck25 slidesSeptember 2026
Investor Presentation (August 2026)Investor deck24 slidesAugust 2026
Investor Presentation (July 2026)Investor deck24 slidesJuly 2026
Investor Presentation (June 2026)Investor deck25 slidesJune 2026
Investor Presentation (May 2026)Investor deck25 slidesMay 2026
Investor Presentation (November 2025)Investor deck26 slidesNovember 2025
Investor Presentation (October 2025)Investor deck26 slidesOctober 2025
Investor Presentation (July 2025)Investor deck25 slidesJuly 2025
Investor Presentation (February 2025)Investor deck23 slidesFebruary 2025
Investor Presentation (April 2024)Investor deck29 slidesApril 2024
All 33 decks
DeckKindSlidesDate
Investor Presentation (November 2023)Investor deck32 slidesNovember 2023
Investor Presentation (October 2023)Investor deck33 slidesOctober 2023
Investor Presentation (February 2023)Investor deck35 slidesFebruary 2023
Investor Presentation (February 2023)Investor deck32 slidesFebruary 2023
Investor Presentation (November 2022)Investor deck34 slidesNovember 2022
Investor Presentation (January 2022)Investor deck35 slidesJanuary 2022
Investor Presentation (December 2021)Investor deck28 slidesDecember 2021
Investor Presentation (July 2021)Investor deck26 slidesJuly 2021
Investor Presentation (February 2019)Investor deck30 slidesFebruary 2019
IPO Roadshow (December 2018)IPO roadshow31 slidesDecember 2018
Investor Presentation (June 2018)Investor deck31 slidesJun 12, 2018
Investor Presentation (June 2018)Investor deck31 slidesJun 12, 2018
Investor Presentation (January 2017)Investor deck28 slidesJanuary 2017
Investor Presentation (October 2016)Investor deck32 slidesOctober 2016
Investor Presentation (November 2015)Investor deck41 slidesNovember 2015
Zeltia — Shareholder Meeting (June 2015)Shareholder meeting43 slidesJun 30, 2015
Zeltia — Shareholder Meeting (June 2013)Shareholder meeting48 slidesJun 12, 2013
Zeltia — Shareholder Meeting (June 2012)Shareholder meeting19 slidesJun 13, 2012
Zeltia — Shareholder Meeting (June 2011)Shareholder meeting40 slidesJun 15, 2011
Zeltia — Shareholder Meeting (June 2010)Shareholder meeting25 slidesJun 29, 2010
Zeltia — CONCORD 2010Conference21 slidesMar 4, 2010
Zeltia — Investor Presentation (March 2010)Investor deck14 slidesMarch 2010
Zeltia — FY2009 Earnings PresentationEarnings8 slidesFeb 25, 2010

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue221.4M174.9M158.2M196.3M229.8M270.0M85.8M162.2M179.3M180.9M
Cost of revenue12.3M8.18M9.61M13.6M16.4M13.7M5.23M35.9M45.7M44.0M
Gross profit209.1M166.7M148.5M182.7M213.4M256.2M80.6M126.3M133.7M137.0M
Research and development95.2M103.5M99.3M83.4M72.2M53.8M50.6M74.0M78.5M78.4M
Selling, general and administrative2.34M2.85M18.3M19.0M17.4M13.5M13.9M17.4M20.7M20.3M
Operating income60.7M6.47M-3.83M44.1M92.4M155.9M-17.5M-14.1M-17.7M-18.7M
Depreciation and amortization8.02M6.77M5.76M5.90M5.58M7.21M6.05M6.38M7.06M7.24M
EBITDA68.7M13.2M1.93M50.0M98.0M163.2M-11.4M-7.70M-10.6M-11.5M
Interest expense6.51M8.53M9.43M11.3M7.68M3.12M3.89M4.14M5.12M5.21M
Income before tax59.7M12.0M-3.62M43.8M95.1M145.6M-21.7M-18.7M-22.9M-24.7M
Income tax-15.3M-14.1M-4.76M-5.57M2.27M8.34M-12.5M-2.50M3.90M-592.0K
Net income75.0M26.1M1.14M49.4M92.9M137.3M-9.18M-5.54M-26.7M-24.1M
Earnings per share, basic4.301.490.062.735.147.49-0.50-0.30-1.45-1.31
Earnings per share, diluted4.301.490.062.735.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents17.8M63.2M60.0M149.8M113.3M96.2M17.6M22.7M24.1M14.3M
Short-term investments149.4M91.3M102.5M32.6M88.5M99.3M3.26M4.13M7.67M18.1M
Receivables39.4M34.7M27.6M29.3M50.9M26.7M13.2M23.5M31.4M62.6M
Inventory54.1M52.0M39.3M27.7M10.5M11.9M8.90M20.6M23.9M22.2M
Current assets283.4M250.2M252.6M275.2M295.2M245.7M50.0M75.1M93.2M121.0M
Property, plant and equipment57.4M55.9M43.9M31.2M27.0M24.7M25.6M25.5M30.6M29.0M
Goodwill02.55M2.55M2.55M
Total assets395.1M349.6M340.5M393.3M368.4M330.3M124.7M157.7M187.7M221.1M
Accounts payable54.3M51.6M40.3M30.0M29.3M21.0M16.5M31.2M35.8M36.7M
Current liabilities93.9M82.7M95.9M97.3M86.3M94.9M60.4M72.4M83.1M87.2M
Long-term debt35.6M39.9M27.0M25.9M33.4M37.7M53.1M64.9M73.6M67.6M
Total debt38.6M43.2M30.4M39.0M49.3M56.7M86.1M93.4M100.0M95.5M
Total liabilities143.2M141.3M147.1M170.3M190.5M227.5M117.2M140.2M164.7M172.6M
Shareholders' equity251.8M208.4M193.4M223.0M177.9M102.7M11.4M21.4M26.9M52.4M
Shares outstanding17.2M17.6M17.9M18.1M18.1M18.3M18.4M18.4M18.4M18.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations53.1M6.03M-13.4M38.3M25.7M278.9M-26.1M-16.3M-1.46M-8.41M
Capital spending-6.46M-15.0M-14.8M-8.85M-7.80M-3.00M-3.91M-2.38M-4.67M-6.09M
Free cash flow46.7M-8.99M-28.3M29.5M17.9M275.9M-30.0M-18.7M-6.12M-14.5M
Cash from investing-60.8M1.03M-43.0M10.9M18.5M-119.0M32.1M22.3M6.00M13.8M
Cash from financing-36.5M-5.35M-32.1M-13.4M-27.4M-73.8M-11.0M-7.26M5.26M1.30M
Dividends paid-13.9M-11.4M-11.7M-11.8M-10.9M-8.82M-8.82M-6.92M-19.9M-20.1M
Share buybacks-34.1M-18.6M-37.9M-50.2M-40.7M-63.7M-7.48M-3.45M-6.19M-4.17M
Change in cash-45.4M3.21M-89.8M36.5M17.1M78.6M-5.11M-1.34M9.80M6.66M

Open Financials

Cap table

Built by 6ix from Pharma Mar SA’s releases

Common shares
17,263,774
Fully diluted
17,263,774

Fully diluted

LineShares
Common shares17,263,774

Share count over time

CountShares
Nov 22, 202617,263,774

Open Cap table

Shareholders

Register

HolderOf the companyAs of
Fernandez Sousa-Faro, Jose Maria11.5%Jun 16, 2026
Andrade Detrell, Montserrat5.3%Jun 16, 2026
Ortega Mera, Sandra5.2%Sep 23, 2025
Fernandez Puentes, Pedro Francisco5.1%Sep 23, 2025
Rosp Corunna Participaciones Empresariales, S.L.5.0%May 26, 2017

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund179KUS$16.4MJul 31, 2026
Goldman Sachs International Small Cap Insights Fund139KUS$12.7MJul 31, 2026
Vanguard Developed Markets Index Fund119KUS$10.2MJun 30, 2026
iShares Core MSCI EAFE ETF106KUS$9.65MJul 31, 2026
The Continental Small Company Series60,597US$5.53MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF56,257US$4.85MJun 30, 2026
iShares MSCI EAFE Small-Cap ETF49,333US$4.5MJul 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund45,372US$4.14MJul 31, 2026
Vanguard European Stock Index Fund28,762US$2.62MJul 31, 2026
Schwab International Small-Cap Equity ETF26,243US$3.06MMay 31, 2026
Show 50 holders
HolderSharesValueAs of
Dimensional International Small Cap ETF24,304US$2.21MJul 31, 2026
iShares Core MSCI Total International Stock ETF22,806US$2.08MJul 31, 2026
Nuveen Quant International Small Cap Equity Fund19,210US$1.75MJul 31, 2026
International Core Equity 2 Portfolio16,910US$1.54MJul 31, 2026
iShares Core MSCI International Developed Markets ETF16,673US$1.52MJul 31, 2026
Old Westbury Small & Mid Cap Strategies Fund13,046US$1.19MJul 31, 2026
Avantis International Equity ETF12,501US$1.46MMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account10,322US$890KJun 30, 2026
Vanguard Total World Stock Index Fund9,212US$840KJul 31, 2026
Fidelity Total International Index Fund8,534US$778KJul 31, 2026
iShares Core MSCI Europe ETF7,912US$722KJul 31, 2026
Dimensional International Core Equity 2 ETF7,798US$709KJul 31, 2026
State Street(R) SPDR(R) S&P(R) International Small Cap ETF7,503US$647KJun 30, 2026
WisdomTree International SmallCap Dividend Fund6,697US$578KJun 30, 2026
Dimensional International Core Equity Market ETF6,435US$585KJul 31, 2026
WisdomTree Dynamic International Equity Fund5,228US$451KJun 30, 2026
Fidelity SAI International Small Cap Index Fund3,961US$361KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio3,618US$312KJun 30, 2026
iShares International Small-Cap Equity Factor ETF2,723US$248KJul 31, 2026
International Social Core Equity Portfolio2,648US$241KJul 31, 2026
WisdomTree Dynamic International SmallCap Equity Fund2,588US$223KJun 30, 2026
Global X Aging Population ETF2,343US$273KMay 31, 2026
WisdomTree International Equity Fund2,295US$198KJun 30, 2026
Vanguard ESG International Stock ETF2,269US$265KMay 31, 2026
International Sustainability Core 1 Portfolio2,056US$187KJul 31, 2026
Dimensional VA International Small Portfolio2,005US$183KJul 31, 2026
Thrivent International Equity Portfolio1,836US$158KJun 30, 2026
Brighthouse/Dimensional International Small Company Portfolio1,831US$158KJun 30, 2026
WisdomTree Europe SmallCap Dividend Fund1,717US$148KJun 30, 2026
iShares MSCI Europe Small-Cap ETF1,572US$143KJul 31, 2026
World ex U.S. Core Equity Portfolio1,111US$101KJul 31, 2026
Thrivent International Equity Fund1,077US$98,213Jul 31, 2026
Dimensional International Sustainability Core 1 ETF1,001US$91,042Jul 31, 2026
International Small Cap Growth Portfolio878US$80,066Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF831US$75,580Jul 31, 2026
iShares MSCI World Small-Cap ETF777US$90,595May 31, 2026
State Street(R) SPDR(R) Portfolio Europe ETF529US$45,633Jun 30, 2026
Voya Multi-Manager International Small Cap Fund507US$46,234Jul 31, 2026
LVIP Dimensional International Core Equity Fund425US$36,638Jun 30, 2026
International Small Company Trust409US$35,259Jun 30, 2026

This page holds 50 of 56 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Fernando Martín-Delgado Santos
CONSEJERO
Buy6EUR 66.50EUR 399Oct 14, 2026
Fernando Martín-Delgado Santos
CONSEJERO
Buy245EUR 66.50EUR 16,293Oct 14, 2026
Fernando Martín-Delgado Santos
CONSEJERO
Buy243EUR 66.55EUR 16,172Oct 14, 2026
Fernando Martín-Delgado Santos
CONSEJERO
Buy6EUR 66.60EUR 400Oct 14, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Miriam Collados GordoCorporate Communications Manager · Since at least Feb 27, 2026
Natalia AmoCapital Markets & Investor Relations · Since at least Feb 27, 2026

Open People

Log in to ask 6ix AI your own questions about Pharma Mar SA.